[Medical treatment of small abdominal aortic aneurysms].
Our expectation is that the numbers of diagnosed small abdominal aortic aneurysms (AAA) will increase in the future. Slowing down the progression of AAAs is of great interest as this could prevent cost-intensive and potential lethal operations. Recent studies indicate that modern medical treatment such as prevention for cardiovascular disease has a spin-off benefit by suppressing the expansion rate of AAAs. According to these studies ACE inhibitors, statins and nonsteroidal anti-inflammatory drugs may have effect, macrolides may have some effect while beta-blockers and calcium-channel blockers have no effect.
Høgh
Annette Langager
AL
Regionshospitalet Viborg, Karkirurgisk Afdeling, Viborg. a_l_hogh@yahoo.dk
Sandermann
Jes
J
Lindholt
Jes S
JS
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D017544:Aortic Aneurysm, Abdominal / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D018942:Macrolides / Q000627:therapeutic use; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018942:Macrolides